BHCM
SAGE

Brevan Howard Capital Management’s Sage Therapeutics SAGE Stock Holding History

Brevan Howard Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-131,987
Closed -$1.05M – 1992
2025
Q1 		$1.05M Buy
+131,987
New +$966K 0.01% 481
2024
Q4 		– Sell
-16,847
Closed -$122K – 1381
2024
Q3 		$122K Sell
16,847
-26,569
-61% -$243K ﹤0.01% 1058
2024
Q2 		$471K Buy
43,416
+23,515
+118% +$301K ﹤0.01% 629
2024
Q1 		$373K Sell
19,901
-1,366
-6% -$31.5K ﹤0.01% 568
2023
Q4 		$461K Buy
+21,267
New +$421K 0.01% 518

Other funds holding SAGE

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return